Halozyme Therapeutics
HALO
#1865
Rank
A$16.29 B
Marketcap
A$142.91
Share price
0.30%
Change (1 day)
31.50%
Change (1 year)

Halozyme Therapeutics (HALO) - Total debt

Total debt on the balance sheet as of June 2026 : A$3.18 Billion

According to Halozyme Therapeutics's latest financial reports the company's total debt is A$3.18 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Halozyme Therapeutics - Total debt on balance sheet (from 2011 to 2026)

Total debt by year

Year Total debt Change
2025-12-31A$3.19 B32.14%
2024-12-31A$2.42 B10.01%
2023-12-31A$2.20 B-0.57%
2022-12-31A$2.21 B83.03%
2021-12-31A$1.20 B134.08%
2020-12-31A$0.51 B-10.16%
2019-12-31A$0.57 B220.52%
2018-12-31A$0.17 B-30.79%
2017-12-31A$0.25 B-13.75%
2016-12-31A$0.30 B339.32%
2015-12-31A$68.4 M12.28%
2014-12-31A$60.92 M9.18%
2013-12-31A$55.79 M86.38%
2012-12-31A$29.93 M
2011-12-31N/A

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Johnson & Johnson
JNJ
A$66.29 B 1,980.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
A$93.82 B 2,843.84%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
A$73.49 B 2,206.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
A$39.95 B 1,153.49%๐Ÿ‡ซ๐Ÿ‡ท France
Baxter
BAX
A$14.35 B 350.33%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
A$0.49 B-84.59%๐Ÿ‡บ๐Ÿ‡ธ USA